Retraction Note: Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol - Top-Institutions - MDSpire

Retraction Note: Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol

  • By

  • Antonio Simone Laganà

  • Luisa Barbaro

  • Alfonsa Pizzo

  • July 15, 2026

Share

Top Institutions in Obgyn

Brief introduction explaining scope and methodology.

  • #1

    Brigham and Women’s Hospital
    Brigham and Women’s Hospital

    Boston, Massachusetts

    Key Differentiators

    • Reproductive Endocrinology
    • Obstetrics & Gynecology

  • #2

    Penn State Health Milton S. Hershey Medical Center
    Penn State Health Milton S. Hershey Medical Center

    Hershey, Pennsylvania

    Key Differentiators

    • Reproductive Endocrinology
    • Infertility

  • #3

    University of Adelaide
    University of Adelaide

    Adelaide, South Australia

    Key Differentiators

    • Reproductive Endocrinology

  • #4

    Shanghai Jiao Tong University
    Shanghai Jiao Tong University

    Shanghai, China

    Key Differentiators

    • Reproductive Endocrinology

  • #5

    Zhengzhou University
    Zhengzhou University

    Zhengzhou, China

    Key Differentiators

    • Reproductive Endocrinology

Original Source(s)

Retraction Note: Evaluation of ovarian function and metabolic factors in women affected by polycystic ovary syndrome after treatment with d-Chiro-Inositol

  • by Antonio Simone Laganà, Luisa Barbaro, Alfonsa Pizzo

  • July 15, 2026

Related Content

When Bad Data Enters the Drug Pipeline

Federal prosecutors allege that a Florida physician and research staff fabricated clinical trial records that were submitted into database systems used to evaluate investigational drugs.

Evidence-based interventions to restore or improve female fertility in women aged 30–42 years: a systematic review by etiology and evidence level

Adjunctive berberine improves hormonal, metabolic, and inflammatory profiles in women with polycystic ovary syndrome: a retrospective case–control study